New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

March 20, 2018 Leave a comment 1,918 Views

Veracyte, Inc. today announced that new data presented at ENDO 2018, the annual meeting of the Endocrine Society, suggest that the Afirma Genomic Sequencing Classifier (GSC) can help significantly more

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: ENDO 2018

New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

Hypercluster – a flexible tool for parallelized unsupervised clustering optimization

Single cells reveal genetic connections of neurodevelopmental disorders

High Throughput RNA-seq Unveil Transcriptome Mystery at Novogene

The importance of selecting a scRNA-Seq protocol based on the biological questions and features of interest

New app enables RNA sequencing data analysis on your smartphone

Ceres Nanosciences receives SBIR grant to adapt its virus capture technology to portable RNA sequencing tools for improved SARS-CoV-2 surveillance

RNA for medical analysis